Arcus Biosciences

Arcus Biosciences is a clinical-stage, global biopharmaceutical company focused on developing innovative therapies for patients with cancer. Founded in 2015, the company is dedicated to designing combination therapies with best-in-class potential, guided by a deep understanding of disease biology. Their approach leverages well-characterized biological pathways to create molecules with outstanding clinical profiles and combinability, enabling rapid development from pre-clinical stages to investigational new drug (IND) filing within 18 months. Arcus is committed to collaborating with the cancer community, including industry partners, patients, and physicians, in their pursuit of cures.

Arcus Biosciences' commitment to "Combining to Cure" is evident in their clinical pipeline, which features multiple product candidates in clinical trials for various cancers. Their research focuses on targeting key immune checkpoints like TIGIT and PD-1, as well as the adenosine axis, to unlock the full potential of the body's natural immune defenses. They are exploring the use of Fc-silent antibodies to minimize side effects while maximizing immune cell activation. Arcus' success is built on a strong foundation of scientific expertise, a highly productive team, and strategic partnerships with leading pharmaceutical companies like AstraZeneca and Gilead Sciences.

Arcus Biosciences offers a flexible work environment, with several job postings specifically mentioning remote work options. The company also provides generous paid time off, including three weeks of vacation, two weeks of sick time, two personal holidays per year, and thirteen paid company holidays.

Arcus Biosciences offers a comprehensive benefits package designed to support employees' well-being and financial security. The package includes comprehensive medical, dental, and vision insurance with a 95% employer contribution, life and disability coverage, flexible spending accounts, a 401(k) plan with an employer match, and an employee assistance plan. Additionally, employees receive three weeks of vacation, two weeks of sick time, two personal holidays, 13 paid company holidays, and an employee stock purchase plan. Work perks include commuter and fitness allowances, holiday parties and social gatherings, and a December holiday shutdown.

Arcus Biosciences is a clinical-stage, global biopharmaceutical company committed to developing best-in-class molecules and combination therapies for people with cancer. Their mission is to improve the lives of cancer patients by blocking tumor-induced immunosuppression and developing highly combinable, best-in-class cancer therapies with the potential to be curative. Their core values include collaboration, innovation, and a relentless pursuit of cures for cancer.

Arcus Biosciences fosters a culture that values teamwork, innovation, and a strong sense of urgency in the pursuit of its mission to defeat cancer. They strive to create a collaborative and supportive environment where employees feel empowered to push boundaries and achieve personal growth. With a commitment to operating with simplicity and common sense, Arcus prioritizes the well-being of its employees, offering a comprehensive benefits package and recognition as a Great Place to Work.

Arcus Biosciences recognizes the importance of diversity in clinical trials, believing that including a wide range of participants allows for a better understanding of how potential new treatments affect different populations. They proactively strive for trial diversity by partnering with both community and academic centers of excellence as study sites, ensuring representation across various demographics. This commitment to diversity in research helps to ensure that potential new treatments are effective and safe for a wider range of individuals.